A population based investigation of early life lung development and immune programming

哮喘和过敏性疾病每年给澳大利亚造成的损失超过78亿美元。我们尚未确定任何实质有效的预防策略。申请者是维多利亚地区一名非常成功的早期临床医生和研究人员。这一合作项目将涉及扩展现有的两个NHMRC项目，除了建立一个新的未经选择的澳大利亚出生队列，以研究哮喘和过敏性疾病的早期生命基因环境决定因素。

Asthma and allergic diseases cost Australia in excess of 7.8 billion per year. We are yet to identify any substantially effective preventative strategies. The applicant is a highly successful early stage clinician-researcher based in regional Victoria. This collaborative project will involve extending two existing NHMRC projects, in addition to establishing a new unselected Australian birth cohort, in to investigate the early life gene-environment determinants of asthma and allergic disease.